London · Delayed Price · Currency is GBP · Price in GBX Coats Group Earnings Call Transcripts
Fiscal Year 2025
-
Delivered record free cash flow and margin expansion in 2025, outpacing declining end markets through strategic M&A, portfolio optimization, and sustainability-driven growth. Upgraded medium-term targets include higher margins and $1 billion cumulative free cash flow.
-
Completion of the OrthoLite acquisition creates a market-leading supplier in footwear components, with $20 million in annualized cost synergies expected by 2028. The new group structure streamlines operations and enhances market reach, with further financial updates anticipated in March.
-
Strong first half with record margins and robust cash flow, supported by growth in apparel and footwear. Acquisition of OrthoLite enhances the growth profile, with cost synergies and EPS accretion expected from year one.
Fiscal Year 2024
-
Revenue grew 9% in constant currency, with EBIT margin up to 18% and EPS up 18%. Apparel and footwear outperformed, while performance materials lagged. U.K. pension liabilities were fully de-risked, supporting strong cash generation and a flexible capital allocation strategy.
-
A GBP 1.3 billion buy-in fully hedges UK pension liabilities, eliminating future deficit contributions and freeing up cash for growth or shareholder returns. The updated capital allocation framework prioritizes organic growth, progressive dividends, and M&A, with leverage managed within target ranges.
-
Strong H1 2024 results with 8% constant currency revenue growth, 18% EBIT margin, and robust cash flow. Apparel and footwear divisions led recovery, while performance materials showed sequential improvement. Full-year outlook raised, with continued focus on sustainability and operational efficiency.